Journal of Cardiac Failure
Volume 16, Issue 2 , Pages 142-149 , February 2010

Medication Adherence is a Mediator of the Relationship Between Ethnicity and Event-Free Survival in Patients With Heart Failure

  • Jia-Rong Wu, PhD, RN

      Affiliations

    • University of Kentucky, College of Nursing, Lexington, KY
    • Corresponding Author InformationReprint requests: Jia-Rong Wu, PhD, RN, University of Kentucky, College of Nursing, 509 CON Building, 760 Rose Street, Lexington, KY 40536-0232. Phone: (859) 257-6921; Fax: (859) 257-0554.
    • ,
  • Terry A. Lennie, PhD, RN

      Affiliations

    • University of Kentucky, College of Nursing, Lexington, KY
    • ,
  • Marla J. De Jong, RN, PhD, CCNS, CCRN, Lt Col

      Affiliations

    • DoD Blast Injury Research Program Coordinating Office, U.S. Army Research and Material Command, Ft. Detrick, MD
    • ,
  • Susan K. Frazier, PhD, RN

      Affiliations

    • University of Kentucky, College of Nursing, Lexington, KY
    • ,
  • Seongkum Heo, PhD, RN

      Affiliations

    • Indiana University, School of Nursing, Indianapolis, IN
    • ,
  • Misook L. Chung, PhD, RN

      Affiliations

    • University of Kentucky, College of Nursing, Lexington, KY
    • ,
  • Debra K. Moser, DNSc, RN, FAAN

      Affiliations

    • University of Kentucky, College of Nursing, Lexington, KY

Received 9 December 2008 ,Revised 5 October 2009 ,Accepted 6 October 2009.

References 

  1. Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics - 2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:e21–e181
  2. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25–e146
  3. Opasich C, Febo O, Riccardi PG, et al. Concomitant factors of decompensation in chronic heart failure. Am J Cardiol. 1996;78:354–357
  4. Norgard NB, Stark JE. Pharmacotherapy for heart failure with left ventricular dysfunction: beyond angiotensin-converting enzyme inhibitors and beta-blockers. Pharmacotherapy. 2008;28:920–931
  5. Fonarow GC, Abraham WT, Albert NM, et al. Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF. J Card Fail. 2007;13:722–731
  6. Rosen D, Decaro MV, Graham MG. Evidence-based treatment of chronic heart failure. Compr Ther. 2007;33:2–17
  7. Chin MH, Goldman L. Factors contributing to the hospitalization of patients with congestive heart failure. Am J Public Health. 1997;87:643–648
  8. Chui MA, Deer M, Bennett SJ, et al. Association between adherence to diuretic therapy and health care utilization in patients with heart failure. Pharmacotherapy. 2003;23:326–332
  9. Happ MB, Naylor MD, Roe-Prior P. Factors contributing to rehospitalization of elderly patients with heart failure. J Cardiovasc Nurs. 1997;11:75–84
  10. Hays RD, Kravitz RL, Mazel RM, et al. The impact of patient adherence on health outcomes for patients with chronic disease in the Medical Outcomes Study. J Behav Med. 1994;17:347–360
  11. Joshi PP, Mohanan CJ, Sengupta SP, et al. Factors precipitating congestive heart failure—role of patient non-compliance. J Assoc Physicians India. 1999;47:294–295
  12. Li H, Morrow-Howell N, Proctor EK. Post-acute home care and hospital readmission of elderly patients with congestive heart failure. Health Soc Work. 2004;29:275–285
  13. Miura T, Kojima R, Mizutani M, et al. Effect of digoxin noncompliance on hospitalization and mortality in patients with heart failure in long-term therapy: a prospective cohort study. Eur J Clin Pharmacol. 2001;57:77–83
  14. Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521–530
  15. Hope CJ, Wu J, Tu W, et al. Association of medication adherence, knowledge, and skills with emergency department visits by adults 50 years or older with congestive heart failure. Am J Health Syst Pharm. 2004;61:2043–2049
  16. Yancy CW. Heart failure in African Americans: a cardiovascular enigma. J Card Fail. 2000;6:183–186
  17. Yancy CW. Heart failure in African Americans. Am J Cardiol. 2005;96:3i–12i
  18. Mitchell JE, Hellkamp AS, Mark DB, et al. Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J. 2008;155:501–506
  19. Yancy CW, Abraham WT, Albert NM, et al. Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry. J Am Coll Cardiol. 2008;51:1675–1684
  20. Evangelista LS, Dracup K, Doering LV. Racial differences in treatment-seeking delays among heart failure patients. J Card Fail. 2002;8:381–386
  21. Alexander M, Grumbach K, Remy L, et al. Congestive heart failure hospitalizations and survival in California: patterns according to race/ethnicity. Am Heart J. 1999;137:919–927
  22. Brown DW, Haldeman GA, Croft JB, et al. Racial or ethnic differences in hospitalization for heart failure among elderly adults: Medicare, 1990 to 2000. Am Heart J. 2005;150:448–454
  23. Deswal A, Petersen NJ, Urbauer DL, et al. Racial variations in quality of care and outcomes in an ambulatory heart failure cohort. Am Heart J. 2006;152:348–354
  24. Mathew J, Wittes J, McSherry F, et al. Racial differences in outcome and treatment effect in congestive heart failure. Am Heart J. 2005;150:968–976
  25. Philbin EF, DiSalvo TG. Influence of race and gender on care process, resource use, and hospital-based outcomes in congestive heart failure. Am J Cardiol. 1998;82:76–81
  26. Rathore SS, Foody JM, Wang Y, et al. Race, quality of care, and outcomes of elderly patients hospitalized with heart failure. JAMA. 2003;289:2517–2524
  27. Bagchi AD, Esposito D, Kim M, et al. Utilization of, and adherence to, drug therapy among medicaid beneficiaries with congestive heart failure. Clin Ther. 2007;29:1771–1783
  28. Wu JR, Moser DK, Chung ML, et al. Predictors of medication adherence using a multidimensional adherence model in patients with heart failure. J Card Fail. 2008;14:603–614
  29. Wu JR, Moser DK, Chung ML, et al. Objectively measured, but not self-reported, medication adherence independently predicts event-free survival in patients with heart failure. J Card Fail. 2008;14:203–210
  30. Wu JR, Lennie TA, De Jong M, et al. Defining an evidence-based cutpoint for medication adherence in heart failure. Circulation. 2008;118:S1039
  31. Wu JR, Moser DK, De Jong MJ, et al. Defining an evidence-based cutpoint for medication adherence in heart failure. Am Heart J. 2009;157:285–291
  32. Dunbar-Jacob J, Bohachick P, Mortimer MK, et al. Medication adherence in persons with cardiovascular disease. J Cardiovasc Nurs. 2003;18:209–218
  33. Bouvy ML, Heerdink ER, Urquhart J, et al. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Card Fail. 2003;9:404–411
  34. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21:1074–1090discussion 1073
  35. Dunbar-Jacob J, Mortimer-Stephens MK. Treatment adherence in chronic disease. J Clin Epidemiol. 2001;54(Suppl 1):S57–S60
  36. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23:1296–1310
  37. Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999;37:846–857
  38. Cheng CW, Woo KS, Chan JC, et al. Association between adherence to statin therapy and lipid control in Hong Kong Chinese patients at high risk of coronary heart disease. Br J Clin Pharmacol. 2004;58:528–535
  39. Kimmel SE, Chen Z, Price M, et al. The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study. Arch Intern Med. 2007;167:229–235
  40. Svarstad BL, Chewning BA, Sleath BL, et al. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37:113–124
  41. Wagner GJ, Ghosh-Dastidar B. Electronic monitoring: adherence assessment or intervention?. HIV Clinical Trials. 2002;3:45–51
  42. Bohachick P, Burke LE, Sereika S, et al. Adherence to angiotensin-converting enzyme inhibitor therapy for heart failure. Prog Cardiovasc Nurs. 2002;17:160–166
  43. Melbourne KM, Geletko SM, Brown SL, et al. Medication adherence in patients with HIV infection: a comparison of two measurement methods. AIDS Read. 1999;9:329–338
  44. Lu M, Safren SA, Skolnik PR, et al. Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav. 2008;12:86–94
  45. Mills RM, Haught WH. Evaluation of heart failure patients: objective parameters to assess functional capacity. Clin Cardiol. 1996;19:455–460
  46. Wu JR, Chung M, Lennie TA, et al. Testing the psychometric properties of the Medication Adherence Scale in patients with heart failure. Heart Lung. 2008;37:334–343
  47. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173–1182
  48. Bennett JA. Mediator and moderator variables in nursing research: conceptual and statistical differences. Res Nurs Health. 2000;23:415–420
  49. MacKinnon DP, Lockwood CM, Hoffman JM, et al. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods. 2002;7:83–104
  50. MacKinnon DP, MacKinnon DP, Dwyer JH. Estimating mediated effects in prevention studies. Eval Rev. 1993;17:144–158
  51. Sonnentag S, Zijlstra FR. Job characteristics and off-job activities as predictors of need for recovery, well-being, and fatigue. J Appl Psychol. 2006;91:330–350
  52. US Department of Health and Human Services. 2nd ed.. Healthy People 2010: with understanding and improving health and objectives for improving health. Vol 1. Washington, DC: US Government Printing Office; 2000;ed
  53. Lafata JE, Pladevall M, Divine G, et al. Are there race/ethnicity differences in outpatient congestive heart failure management, hospital use, and mortality among an insured population?. Med Care. 2004;42:680–689
  54. Prisant LM, Thomas KL, Lewis EF, et al. Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both. J Am Coll Cardiol. 2008;51:1865–1871
  55. Small KM, Wagoner LE, Levin AM, et al. Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med. 2002;347:1135–1142
  56. Bourassa MG, Gurne O, Bangdiwala SI, et al. Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators. J Am Coll Cardiol. 1993;22:14A–19A
  57. Yancy CW. Treatment of heart failure in African Americans: clinical update. Ethn Dis. 2002;12:S1-19-26
  58. Yancy CW. Heart failure in African Americans: pathophysiology and treatment. J Card Fail. 2003;9:S210–S215
  59. Yancy CW. The prevention of heart failure in minority communities and discrepancies in health care delivery systems. Med Clin North Am. 2004;88:1347–1368xii-xiii
  60. East MA, Peterson ED, Shaw LK, et al. Racial differences in the outcomes of patients with diastolic heart failure. Am Heart J. 2004;148:151–156
  61. Vaccarino V, Gahbauer E, Kasl SV, et al. Differences between African Americans and whites in the outcome of heart failure: evidence for a greater functional decline in African Americans. Am Heart J. 2002;143:1058–1067
  62. Diercks DB, Fonarow GC, Kirk JD, et al. Risk stratification in women enrolled in the Acute Decompensated Heart Failure National Registry Emergency Module (ADHERE-EM). Acad Emerg Med. 2008;15:151–158
  63. Mullens W, Abrahams Z, Sokos G, et al. Gender differences in patients admitted with advanced decompensated heart failure. Am J Cardiol. 2008;102:454–458
  64. Evangelista LS, Berg J, Dracup K. Relationship between psychosocial variables and compliance in patients with heart failure. Heart Lung. 2001;30:294–301
  65. Graveley EA, Oseasohn CS. Multiple drug regimens: Medication compliance among veterans 65 years and older. Res. Nurs Health. 1991;14:51–58
  66. Rich MW, Gray DB, Beckham V, et al. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med. 1996;101:270–276
  67. Conn V, Taylor S, Miller R. Cognitive impairment and medication adherence. J Gerontol Nurs. 1994;20:41–47
  68. Morgan AL, Masoudi FA, Havranek EP, et al. Difficulty taking medications, depression, and health status in heart failure patients. J Card Fail. 2006;12:54–60
  69. Akincigil A, Bowblis JR, Levin C, et al. Long-term adherence to evidence based secondary prevention therapies after acute myocardial infarction. J Gen Intern Med. 2007;23:115–121
  70. Bosworth HB, Dudley T, Olsen MK, et al. Racial differences in blood pressure control: potential explanatory factors. Am J Med. 2006;119:70;e79–15
  71. Li X, Margolick JB, Conover CS, et al. Interruption and discontinuation of highly active antiretroviral therapy in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr. 2005;38:320–328
  72. Klein D, Turvey C, Wallace R. Elders who delay medication because of cost: health insurance, demographic, health, and financial correlates. Gerontologist. 2004;44:779–787
  73. Gellad WF, Haas JS, Safran DG. Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study. J Gen Intern Med. 2007;22:1572–1578
  74. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555–567
  75. van der Wal MH, Jaarsma T, Moser DK, et al. Compliance in heart failure patients: the importance of knowledge and beliefs. Eur Heart J. 2006;27:434–440
  76. Welsh JD, Heiser RM, Schooler MP, et al. Characteristics and treatment of patients with heart failure in the emergency department. J Emerg Nurs. 2002;28:126–131
  77. Kim EY, Han HR, Jeong S, et al. Does knowledge matter? Intentional medication nonadherence among middle-aged Korean Americans with high blood pressure. J Cardiovasc Nurs. 2007;22:397–404
  78. Bennett SJ, Cordes DK, Westmoreland G, et al. Self-care strategies for symptom management in patients with chronic heart failure. Nurs Res. 2000;49:139–145
  79. Bennett SJ, Milgrom LB, Champion V, et al. Beliefs about medication and dietary compliance in people with heart failure: an instrument development study. Heart Lung. 1997;26:273–279
  80. Siegel K, Karus D, Schrimshaw EW. Racial differences in attitudes toward protease inhibitors among older HIV-infected men. AIDS Care. 2000;12:423–434
  81. Kaplan RC, Bhalodkar NC, Brown DL, et al. Differences by age and race/ethnicity in knowledge about hypercholesterolemia. Cardiol Rev. 2006;14:1–6
  82. Mochari H, Ferris A, Adigopula S, et al. Cardiovascular disease knowledge, medication adherence, and barriers to preventive action in a minority population. Prev Cardiol. 2007;10:190–195
  83. Ferguson TF, Stewart KE, Funkhouser E, et al. Patient-perceived barriers to antiretroviral adherence: associations with race. AIDS Care. 2002;14:607–617
  84. Kressin NR, Wang F, Long J, et al. Hypertensive patients' race, health beliefs, process of care, and medication adherence. J Gen Intern Med. 2007;22:768–774

 Supported by funding from the Philips Medical-American Association of Critical Care Nurses Outcomes Grant, University of Kentucky General Clinical Research Center (M01RR02602), American Heart Association Great River Affiliate Post-doctoral Fellowship to Jia-Rong Wu, grant #R01 NR008567 from the National Institute of Nursing Research and a Center grant to the University of Kentucky, College of Nursing from NIH, NINR, 1P20NR010679.

 The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Nursing Research or the National Institutes of Health. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Air Force or the Department of Defense.

PII: S1071-9164(09)01127-0

doi: 10.1016/j.cardfail.2009.10.017

Journal of Cardiac Failure
Volume 16, Issue 2 , Pages 142-149 , February 2010

Article Tools

* Image Usage & Resolution